Fetuin-A Modulates Tumor Growth and Invasion in a Basal-like Triple Negative Breast Cancer Cell line, MDA-MB-468
Journal of Pharmacy and Pharmacology Research · 2025
DOI: 10.26502/fjppr.0103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology Research, 2025. Verfasst von Divya B Kenchappa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, 1005 Dr. D.B. Todd Blvd., Nashville, TN 37208. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIMHD NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, 1005 Dr. D.B. Todd Blvd., Nashville, TN 37208.
- Present Address: Department of Oncology, Albert Einstein College of Medicine, Bronx, NY 10461.
- Department of Biomedical Science, Graduate School, Meharry Medical College, 1005 D.B. Todd Blvd., Nashville, TN 37208.
- Department of Pathology, Meharry Medical College, 1005 D.B. Todd Blvd., Nashville, TN 37208.
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIMHD NIH HHS
Zitieren
APA
Kenchappa, D. B., Korolkova, O., Sakwe, N., Odiase, P., Izban, M. G., Sakwe, A., & Ochieng, J. (2025). Fetuin-A Modulates Tumor Growth and Invasion in a Basal-like Triple Negative Breast Cancer Cell line, MDA-MB-468. Journal of Pharmacy and Pharmacology Research. https://doi.org/10.26502/fjppr.0103
Vancouver
Kenchappa DB, Korolkova O, Sakwe N, Odiase P, Izban MG, Sakwe A, et al. Fetuin-A Modulates Tumor Growth and Invasion in a Basal-like Triple Negative Breast Cancer Cell line, MDA-MB-468. Journal of Pharmacy and Pharmacology Research. 2025. doi:10.26502/fjppr.0103
BibTeX
@article{Kenchappa2025,
author = {Kenchappa, Divya B and Korolkova, Olga and Sakwe, Nobelle and Odiase, Peace and Izban, Michael G and Sakwe, Amos and Ochieng, Josiah},
title = {Fetuin-A Modulates Tumor Growth and Invasion in a Basal-like Triple Negative Breast Cancer Cell line, MDA-MB-468},
journal = {Journal of Pharmacy and Pharmacology Research},
year = {2025},
doi = {10.26502/fjppr.0103}
}
EUVIMED